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• Advances in genetic engineering production of therapeutics and vaccines for 
human and animals in the form of recombinant proteins
• The recombinant proteins form a new class of drugs 
• for many ailments like genetic disorders, cancer, hypertension and AIDS for which we 
have no better treatment or cure 
• In addition, use of DNA, proteins and enzymes in diagnostics is increasing 
exponentially
• Industrial uses of enzymes in food, textile, leather, detergent, medicinal chemistry

























• Prokaryotic systems: generally easier to handle 
satisfactory for most purposes
limitations in using: eukaryotic proteins post-translational modifications
Like proper folding, glycosylation, phosphorylation, formation of                                                                     
disulphide bridges
• There is no universal expression system for all proteins
• All expression systems have some advantages as well as some disadvantages (1)
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Comparison of different properties of protein expression systems (from highest to lowest)(3)
Easy to use Speed Cost efficiency Time required post translational 
modification
CFPS CFPS Mammalian cell Mammalian cell Mammalian cell Mammalian cell
Bacterial system Bacterial system Insect cell Insect cell Insect cell Insect cell
Yeasts Yeasts Yeasts Bacterial system Yeasts Yeasts
Insect cell Insect cell Bacterial system Yeasts Bacterial system Bacterial system





choosing a expression system:




• the biological activity of protein
• Flexibility
• Speed












• Cell-free protein synthesis(also known as in vitro protein synthesis or CFPS):
• the production of protein using biological machinery in a cell-free system
• without the use of living cells
• The CFPS reaction lacks a cellular membrane and a functional genome
• consequently is not constrained by the cell’s life objectives 
• CFPS has been implemented using cell extracts from numerous different organisms
• with their unique biochemistries enabling a broad set of applications
• In some cases higher protein titers can be achieved using CFPS 
• all energy in the system is channeled toward producing the protein of interest (5-8)
Cell-Free Protein Synthesis(CFPS):
12
• CFPS has been used for about 60 years
• the first elucidation of a codon was done by Marshall Nirenberg                                   
and Heinrich J. Matthaei in 1961.
• They used a cell-free system to translate a poly-uracil RNA sequence 
• discovered that the polypeptide they had synthesized consisted of only the amino acid 
phenylalanine
• the codon UUU specified the amino-acid phenylalanine
• Extending this work, Nirenberg and his coworkers were able to determine the 
nucleotide makeup of each codon(9)
History:
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• the expression of proteins including large proteins and membrane proteins 
which are challenging for traditional expression systems
• The advantages of CFPS         use for various applications such as:
• the production of difficult-to-synthesize proteins
• large proteins





• CFPS enables direct access and control of the translation environment 
• which is advantageous for a number of applications including:
co-translational solubilisation of membrane proteins, optimisation
of protein production, incorporation of non-natural amino acids, 
selective and site-specific labelling
• Due to the open nature of the system, different expression conditions can 
be screened such as:
pH, temperatures, and chaperones(5, 10, 11)
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• Since there is no need to maintain cell viability
• toxic proteins can be produced.
• Other miscellaneous applications include:




A comparison of cell-free and in vivo protein 
synthesis methods:
• advantages of CFPS:
• These include the elimination of the 
transformation step
• an open reaction for direct manipulation of the 
environment of protein production
• the lack of constraints based on the cell’s life 
objectives
• the channeling of all energy toward production 
of the protein of interest
• the ability to store extracts for on-demand 
protein expression(6)
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• CFPS reactions are flexible in their setup
• allowing users to utilize a variety of reaction formats
such as batch, continuous flow, and continuous exchange 
• Batch reactions contain all the necessary reactants within a single reaction vessel
• Continuous exchange formats utilize a dialysis membrane 
• allows reactants to move into the reaction and byproducts to move out
• while the protein of interest remains in the reaction compartment
• Continuous flow formats allow a feed solution to be continuously pumped into the 
reaction chamber 




• the basic steps for a cell-free platform are analogous across platforms 
• culturing the cell line of interest from which transcription and 
translation machinery are to be extracted
• lysing the cells while maintaining ribosomal activity in the lysate
• prepare cell extract by clarifying the lysate 




• Lysis methods are extremely variable
• commonly used methods include:
homogenization, sonication, freeze thaw, nitrogen cavitation
bead beating
• Extract preparation varies by:
• centrifugation
• Dialysis
• treatment with nucleases 
• to remove endogenous DNA or RNA(6,12)
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General workflow for preparation of cell-free extract and set up of CFPS reactions(7)
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• Common components of a cell-free reaction include:
a cell extract, an energy source, a supply of amino acids, cofactors such 
as magnesium, and the DNA with the desired genes
• A cell extract is obtained by lysing the cell of interest
• centrifuging out the cell walls, DNA genome, and other debris
• The remains are the necessary cell machinery including:
ribosomes, aminoacyl-tRNA synthetases, translation initiation and 
elongation factors, nucleases, etc.
• Cell-free in vitro protein expression can be performed in so-called “coupled” systems




• Two types of DNA can be used in CFPS: 
plasmids and linear expression templates (LETs)
• Plasmids are circular, and only made inside cells
• LETs can be made much more effectively via PCR 
• LETs are easier and faster to make
• plasmid yields are usually much higher in CFPS
• Common energy source in CFPS: 








• Relatively low cost
• High translation speed
• Genetically modified strains available
• Relatively tolerant of additives 
Disadvantages:
• No post-translational modifications of 
the eukaryotic systems
• Codon usage optimization is required





• Generally highest yield among eukaryotic 
cell-free systems
• High ratio of soluble expression
• Suitable for the synthesis of large proteins 
(∼200 kDa)
• Relatively high cost due to time-consuming 
extract preparation
• Some background phosphorylation was 





• Suitable for the synthesis of large proteins
• Cap independent translation
• N-glycosylation possible
• Formation of disulfide bridges
• Relatively new system
• Lower protein yield than E. coli or wheat germ 
systems






• Cap independent translation
• Often used in research
• Sensitive to additives
• No glycosylation




• Some protein modification
• Low yield






• One challenge associated with CFPS 
• the degradation of the DNA by endogenous nucleases and exonucleases
in the cell extract
• This is particularly problematic with LETs
• Because of LET vulnerability        much research today is focused on 
optimizing CFPS LET yields 
• PURE extracts can also be made         eliminating the concern of 
nucleases
• These extracts are expensive to make 
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